Evidence map›Paper›PMID 35276982›Full record

ReviewNutrients2022

Oleanolic Acid: Extraction, Characterization and Biological Activity.

José M Castellano, Sara Ramos-Romero, Javier S Perona

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 126 papers.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed
21.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05529953 nacompletednot on this map

Bioavailability Assays of Oleanolic Acid, Formulated as Functional Olive Oil, in Healthy Subjects. Pharmacokinetic Analysis and Study of Its Integration in Postprandial Human Triglyceride-Rich Lipoproteins

TypeinterventionalSponsorSpanish National Research CouncilRan2021 to 2021Enrolled22ConditionsHealthy Subjects, BioavailabilityArmsOleanolic acid (CAS no. 598-02-1, PubChem CID 10494), Control commercial olive oil
NCT06030544 phase2active not recruitingnot on this map

Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)

TypeinterventionalSponsorSpanish National Research CouncilRan2022 to 2025Enrolled100ConditionsDiabetic Patients, Type II Diabetes MellitusArmsOA-enriched functional olive oil, commercial olive oil
3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 279 citations in OpenAlex.

  1. Article
  2. Callus Induction inPlants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Chemical Characteristics and Antimicrobial Activity ofMolecules (Basel, Switzerland) · 2026
    Article
  12. Terpenoids in Young Cladodes of Wild, Semi-Domesticated, and Domesticated Prickly Pear Cactus.Plant foods for human nutrition (Dordrecht, Netherlands) · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

José M CastellanoDepartment of Food and Health, Instituto de la Grasa-CSIC, Campus of the University Pablo de Olavide, Building 46, 41013 Seville, Spain.ORCID 0000-0003-3051-3264
Sara Ramos-RomeroDepartment of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain.
Javier S PeronaDepartment of Food and Health, Instituto de la Grasa-CSIC, Campus of the University Pablo de Olavide, Building 46, 41013 Seville, Spain.ORCID 0000-0001-5919-993X
Instituto de la Grasa · ESUniversitat de Barcelona · ES

Funding

Spanish National Research Agency PID2019-107837RB-I00
6 · The paper itself

Abstract

Oleanolic acid, a pentacyclic triterpenoid ubiquitously present in the plant kingdom, is receiving outstanding attention from the scientific community due to its biological activity against multiple diseases. Oleanolic acid is endowed with a wide range of biological activities with therapeutic potential by means of complex and multifactorial mechanisms. There is evidence suggesting that oleanolic acid might be effective against dyslipidemia, diabetes and metabolic syndrome, through enhancing insulin response, preserving the functionality and survival of β-cells and protecting against diabetes complications. In addition, several other functions have been proposed, including antiviral, anti-HIV, antibacterial, antifungal, anticarcinogenic, anti-inflammatory, hepatoprotective, gastroprotective, hypolipidemic and anti-atherosclerotic activities, as well as interfering in several stages of the development of different types of cancer; however, due to its hydrophobic nature, oleanolic acid is almost insoluble in water, which has led to a number of approaches to enhance its biopharmaceutical properties. In this scenario, the present review aimed to summarize the current knowledge and the research progress made in the last years on the extraction and characterization of oleanolic acid and its biological activities and the underlying mechanisms of action.

Indexed as

Insulin-Secreting CellsOleanolic AcidTriterpenesAnti-Inflammatory AgentsPlantsAnti-Inflammatory AgentsOleanolic AcidTriterpenesbiological activitiescharacterizationdiseasesmechanismsoleanolic acidstructure

Identifiers

PMID35276982
PMCPMC8838233
OpenAlexW4210407593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.